Medial Approach for Identification of Recurrent Laryngeal Nerve in Locally Advanced Differentiated Thyroid Carcinoma: Revisited.
1/5 보강
Recurrent laryngeal nerve injury is a well-recognized and potentially catastrophic complication of thyroidectomy.
APA
Mishra SK, Yadav SK, Bansal N (2022). Medial Approach for Identification of Recurrent Laryngeal Nerve in Locally Advanced Differentiated Thyroid Carcinoma: Revisited.. Indian journal of surgical oncology, 13(1), 87-91. https://doi.org/10.1007/s13193-020-01115-5
MLA
Mishra SK, et al.. "Medial Approach for Identification of Recurrent Laryngeal Nerve in Locally Advanced Differentiated Thyroid Carcinoma: Revisited.." Indian journal of surgical oncology, vol. 13, no. 1, 2022, pp. 87-91.
PMID
35462670 ↗
Abstract 한글 요약
Recurrent laryngeal nerve injury is a well-recognized and potentially catastrophic complication of thyroidectomy. In literature, four approaches have been described for identification of RLN, the superior, lateral, medial, and inferior approaches. But medial approach is lesser known amongst surgeons. Locally infiltrative thyroid cancer with extensive lymph nodal metastasis in central and lateral compartment sometimes makes it difficult to identify RLN by any of these standard approaches described above. A medial approach was described where RLN is identified as it extends up to interdigitate with the trunk or the branches of the inferior thyroid artery. We present here a new alternative technique for identification of recurrent laryngeal nerve through modified medial approach that was used in difficult thyroidectomies.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Microfluidic-based patient-derived organoids recapitulate thyroid cancer heterogeneity and reveal NF-κB-driven maturation for precision therapy.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- CHI3L1 Is Associated With TP53 Signaling and Promotes Papillary Thyroid Carcinoma Progression.
- DNA Damage and Repair in Thyroid Physiology and Disease.
- Impact of health information prescription in thyroid cancer.